Oncogene : Impact Factor & More
eISSN: 1476-5594pISSN: 0950-9232
Share this on:
Key Metrics
CiteScore 
15.6
Impact Factor
5 - 10
Scite Index
0.94 5-Year SI
SNIP
1.79
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Oncogene
Oncogene Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Weekly |
| General Details | |
| Language | English |
| Frequency | Weekly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Oncogene ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Oncogene
Methodological considerations for centromere copy number analyses in HER2-positive metastatic breast cancer.
- 1 Jun 2026
- Oncogene
Editorial Expression of Concern: p53 promotes adenoviral replication and increases late viral gene expression.
- 1 Jun 2026
- Oncogene
NDRG2 orchestrates circadian clock stability to suppress tumorigenesis and potentiate oxaliplatin response in colorectal cancer.
- 19 May 2026
- Oncogene
ESR1 fusion proteins in breast cancer: distinguishing oncogenic drivers from passenger events.
- 14 May 2026
- Oncogene
Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.
- 11 May 2026
- Oncogene
Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
- 11 May 2026
- Oncogene
Methodological considerations for centromere copy number analyses in HER2-positive metastatic breast cancer.
- 1 Jun 2026
- Oncogene
Editorial Expression of Concern: p53 promotes adenoviral replication and increases late viral gene expression.
- 1 Jun 2026
- Oncogene
NDRG2 orchestrates circadian clock stability to suppress tumorigenesis and potentiate oxaliplatin response in colorectal cancer.
- 19 May 2026
- Oncogene
ESR1 fusion proteins in breast cancer: distinguishing oncogenic drivers from passenger events.
- 14 May 2026
- Oncogene
Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.
- 11 May 2026
- Oncogene
Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
- 11 May 2026
- Oncogene
FAQs on Oncogene
How long has Oncogene been actively publishing? 
What is the publishing frequency of Oncogene?
How many articles did Oncogene publish last year?
What is the eISSN & pISSN for Oncogene?
What is Citescore for Oncogene?
What is SNIP score for Oncogene?
Who is the publisher of Oncogene?
